Useful resources |
Immunotherapy for IgM anti-myelin-associated glycoprotein paraprotein-associated peripheral neuropathies (Cochrane Review) ABSTRACT Background: Serum monoclonal anti-myelin associated glycoprotein antibodies may be pathogenic in some people with IgM paraprotein and demyelinating neuropathy. Immunotherapies aimed at reducing the level of these antibodies might be expected to be beneficial. |
Full article: The full article is available on Wiley InterScience at http://www.thecochranelibrary.com |